RIYADH: The Saudi aid agency KSrelief is continuing to support patients from the most vulnerable groups, reflecting the Kingdom’s values of compassion and generosity.
KSrelief funded the treatment of Yazan Sami Nasman, a nine-year-old Palestinian child from the Gaza Strip who was suffering with a tumor in the lymphatic system, the Saudi Press Agency reported.
The intervention followed a deterioration in his health, with medical reports indicating the need for advanced treatment and specialized intensive care unavailable in Gaza due to challenges in its healthcare system.
After coordination through official channels, the child was transferred to Jordan for treatment at the King Hussein Cancer Center in Amman, the SPA added.
He now undergoes periodic examinations to assess his response to treatment. These are carried out by a specialized pediatric lymphatic tumor team and they help to control his condition and minimize potential complications.
KSrelief signed a cooperation agreement with the King Hussein Cancer Center in 2024 to treat cancer patients from Gaza, aiming to save those deprived of treatment due to difficult healthcare conditions.
This effort is part of Saudi Arabia’s humanitarian and medical initiatives through KSrelief, providing essential healthcare to people in need worldwide.
KSrelief last year funded treatment for seven-year-old Eileen Rami Al-Kilani from Gaza at the King Hussein Cancer Center, addressing her colon cancer.
The agency also facilitated surgery for Palestinian child Mira Suhaib Aqqad — who had a congenital heart defect — at King Abdulaziz Medical City.
KSrelief supported six-year-old Mohammed Abdullah Al-Kutnan, who was suffering from neuroblastoma, by urgently transferring him from Gaza to Jordan for treatment.
In addition, KSrelief provided emergency care for three-year-old Seleen Shadi Abdul Salam from Gaza, who is battling acute leukemia.
KSrelief is currently running a specialized project with the King Hussein Cancer Center to treat 150 Palestinian cancer patients from Gaza, at a cost exceeding $3.6 million.